The efficacy and safety of anamorelin among patients with diabetes.
Ando K, Naito T, Hamauchi S, Miura K, Nishibori Y, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Kodama H, Yabe M, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ryo K, Wakuda K, Ono A, Kenmotsu H, Murakami H, Yamazaki K, Takahashi T.
Ando K, et al. Among authors: nishibori y.
Int J Clin Oncol. 2024 Aug;29(8):1115-1121. doi: 10.1007/s10147-024-02546-8. Epub 2024 May 9.
Int J Clin Oncol. 2024.
PMID: 38722487